Add-on maintenance treatment for patients 12 and older with severe eosinophilic asthma. See more
FASENRA is not used to treat other problems caused by eosinophils and is not used to treat sudden breathing problems.
Your results may vary.
FASENRA was studied in a robust clinical trial program for targeted therapies in severe eosinophilic asthma. FASENRA added to standard asthma treatments worked better than standard treatments alone. FASENRA is given by a healthcare provider, only once every 8 weeks after the first 2 months.‡
*In a 48-week clinical trial of FASENRA vs placebo + existing medicines. In a 56-week clinical trial, FASENRA reduced the occurrence of severe asthma attacks by 28% compared with placebo + existing medicines.
†Median reduction, compared with 25% with placebo and existing medicines in a 28-week clinical trial of FASENRA vs placebo + steroid + existing medicines.
‡First 3 doses given on day 1, week 4, and week 8.
Do not receive FASENRA if you are allergic to benralizumab or any of the ingredients in FASENRA. Do not use to treat sudden breathing problems.
Do not stop taking your other asthma medicines unless instructed to do so by your healthcare provider.
The most common side effects of FASENRA include: headache and sore throat. These are not all the possible side effects of FASENRA.
FASENRA is a prescription medicine used with other asthma medicines for the maintenance treatment of asthma in people 12 years and older whose asthma is not controlled with their current asthma medicines. FASENRA helps prevent severe asthma attacks (exacerbations) and may improve your breathing. Medicines such as FASENRA reduce blood eosinophils. Eosinophils are a type of white blood cell that may contribute to your asthma.
FASENRA is not used to treat other problems caused by eosinophils and is not used to treat sudden breathing problems. Tell your health care provider if your asthma does not get better or if it gets worse after you start treatment with FASENRA.
It is not known if FASENRA is safe and effective in children under 12 years of age.